New advances in laparoscopic treatment of morbid obesity.

The prevalence of obesity in the United States (U.S.) is increasing to epidemic proportions.

Laparoscopic biliopancreatic diversion with duodenal switch: three different duodeno-ileal anastomotic techniques and initial experience.

Background: The duodenal switch (DS) is a variant of the biliopancreatic diversion (BPD) for surgical treatment of morbid obesity. Absence of dumping syndrome leads to a high quality of life in these patients. The complexity of the laparoscopic BPD-DS is high, and the technical aspects of the duodeno-ileostomy are still under consideration.

Outcome after laparoscopic adjustable gastric banding, using the Lap-Band and the Heliogast band: a prospective randomized study.

Background: A study was performed to assess the usefulness and efficacy of a new type of band (Heliogast) for laparoscopic adjustable gastric banding (LAGB) for the treatment of morbid obesity, compared with the Lap-Band.

Method: From January to May 2001, a prospective randomized study of 60 LAGB procedures was conducted: group I (n=30), the Lap-Band system (INAMED); group II (n=30), the Heliogast band (Hélioscopie). We implanted the devices using the 2-step technique (pars flaccida to peri-gastric) by laparoscopy.

Outcome after laparoscopic adjustable gastric banding - 8 years experience.

Background: Laparoscopic adjustable gastric banding (LAGB) has been our choice operation for morbid obesity since 1994. Despite a long list of publications about the LAGB during recent years, the evidence with regard to long-term weight loss after LAGB has been rather sparse. The outcome of the first 100 patients and the total number of 984 LAGB procedures were evaluated.

[Indications, technique and results of laparoscopic gastric bypass operation].

Unlabelled: Laparoscopic Roux en-Y-Gastric Bypass (RYGB) has been performed in our initial series in 50 patients.

Methods: The results of surgery, technique, including 3-12 months follow-up, are described with 100% follow-up in the first 50 patients. Weight loss, operative morbidity and relief of co-morbidities have been thoroughly studied in a prospective way.